1. Ahearn, E. P., Juergens, T., Cordes, T., Becker, T., & Krahn, D. (2011). A review of atypical antipsychotic medications for posttraumatic stress disorder. International Clinical Psychopharmacology, 26(4), 193–200.
2. Amos, T., Stein, D. J., & Ipser, J. C. (2014). Pharmacological interventions for preventing post-traumatic stress disorder (PTBS). Cochrane Database of Systematic Reviews, (7), CD006239.
3. APA (American Psychiatric Association). (1980). Diagnostic and statistical manual of mental disorders (3. Aufl.). Washington, DC: American Psychiatric Association.
4. Asnis, G. M., Kohn, S. R., Henderson, M., & Brown, N. L. (2004). SSRIs versus non-SSRIs in post-traumatic stress disorder: An update with recommendations. Drugs, 64(4), 383–404.
5. Baker, D. G., Diamond, B. I., Gillette, G., Hamner, M., Katzelnick, D., Keller, T., Mellman, T. A., Pontius, E., Rosenthal, M., & Tucker, P. (1995). A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology, 122, 386–389.